These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 36797433

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple-negative breast cancer.
    Shao Z, Ma X, Zhang Y, Sun Y, Lv W, He K, Xia R, Wang P, Gao X.
    Mol Carcinog; 2020 May; 59(5):533-544. PubMed ID: 32181526
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Upregulation of FGF9 and NOVA1 in cancer-associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer.
    Zhang B, Liu Y, Yu J, Lin X.
    Drug Dev Res; 2024 May; 85(3):e22185. PubMed ID: 38657094
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G, Fan X, Hao M, Wang J, Zhou X, Sun X.
    Mol Cancer; 2016 Apr 30; 15(1):30. PubMed ID: 27130446
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased expression of REG3A promotes tumorigenic behavior in triple negative breast cancer cells.
    Jin X, Yang S, Lu X, Chen X, Dai W.
    Breast Cancer Res; 2024 Jun 05; 26(1):92. PubMed ID: 38840145
    [Abstract] [Full Text] [Related]

  • 13. hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways.
    Park S, Sung Y, Jeong J, Choi M, Lee J, Kwon W, Jang S, Park SJ, Kim HS, Lee MH, Kim DJ, Liu K, Kim SH, Dong Z, Ryoo ZY, Kim MO.
    Oncotarget; 2017 Jun 06; 8(23):37115-37127. PubMed ID: 28415749
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. USP1-mediated deubiquitination of KDM1A promotes the malignant progression of triple-negative breast cancer.
    Su Y, Du Y, He W.
    J Biochem Mol Toxicol; 2024 Oct 06; 38(10):e23864. PubMed ID: 39318028
    [Abstract] [Full Text] [Related]

  • 18. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
    Singel SM, Batten K, Cornelius C, Jia G, Fasciani G, Barron SL, Wright WE, Shay JW.
    Breast Cancer Res; 2014 Mar 19; 16(2):R28. PubMed ID: 24642040
    [Abstract] [Full Text] [Related]

  • 19. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B, Wang J, Dai D, Zhou Q, Guo X, Tian Z, Huang X, Yang L, Tang H, Xie X.
    J Exp Clin Cancer Res; 2017 May 12; 36(1):65. PubMed ID: 28494797
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.